PROCOS in Piemonte: a story of growth and investment in the pharmaceutical industry

PROCOS specializes in the contract development and GMP manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates, providing integrated services to the global pharmaceutical industry. Founded in 1945 and headquartered in Cameri, in the Novara province, the company has been part of the Japanese Group CBC Co., Ltd. since 2006. Today, PROCOS employs more than 550 people, operates internationally and generates annual revenues of approximately €250 million, serving leading pharmaceutical companies worldwide.

The project in Piemonte

Piemonte has always been PROCOS' home. Since its foundation, the company has grown together with the local community, from the region's strong industrial tradition, highly skilled workforce, strategic location, and excellent manufacturing ecosystem. These strengths, combined with a culture of innovation and collaboration, continue to make Piemonte the ideal place for PROCOS' long-term growth and investment.

Since the acquisition by the CBC Group in 2006, PROCOS has experienced remarkable growth through continuous investment. The company has grown from around 200 to more than 500 employees, while annual revenues have increased from approximately €55 million to over €250 million. The latest milestone is the new R11 production unit, a project worth more than €100 million featuring cutting-edge technologies that will increase production capacity by approximately 25% and further strengthen PROCOS' position as a reliable global partner.
Looking ahead, approximately €200 million in additional investments have been announced over the next eight years, together with plans to create around 150 new jobs, reaffirming PROCOS' commitment to the sustainable growth of the region.

For more information, please write to: This email address is being protected from spambots. You need JavaScript enabled to view it.